Publications

Granger, BB, Locke, SC, Bowers, M, Sawyer, T, Shang, H, Abernethy, AP, Bloomfield, RA, and Gilliss, CL. "The Digital Drag and Drop Pillbox: Design and Feasibility of a Skill-based Education Model to Improve Medication Management." The Journal of cardiovascular nursing 32, no. 5 (September 2017): E14-E20.

PMID
28282304
Full Text

Randazzo, DM, McSherry, F, Herndon, JE, Affronti, ML, Lipp, ES, Flahiff, C, Miller, E, Woodring, S, Freeman, M, Healy, P, Minchew, J, Boulton, S, Desjardins, A, Vlahovic, G, Friedman, HS, Keir, S, and Peters, KB. "A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population." Journal of neuro-oncology 134, no. 2 (September 2017): 363-369.

PMID
28669010
Full Text

Kaufmann, TL, and Kamal, AH. "Oncology and Palliative Care Integration: Cocreating Quality and Value in the Era of Health Care Reform." Journal of oncology practice 13, no. 9 (September 2017): 580-588.

PMID
28682666
Full Text

Armstrong, AJ, Lin, P, Higano, CS, Iversen, P, Sternberg, CN, Tombal, B, Phung, D, Parli, T, Krivoshik, A, and Beer, TM. "Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide." September 2017.

Scholars@Duke

Min, Y, Roche, KC, Tian, S, Eblan, MJ, McKinnon, KP, Caster, JM, Chai, S, Herring, LE, Zhang, L, Zhang, T, DeSimone, JM, Tepper, JE, Vincent, BG, Serody, JS, and Wang, AZ. "Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy." Nature nanotechnology 12, no. 9 (September 2017): 877-882.

PMID
28650437
Full Text

Beasley, GM, Hu, Y, Youngwirth, L, Scheri, RP, Salama, AK, Rossfeld, K, Gardezi, S, Agnese, DM, Howard, JH, Tyler, DS, Slingluff, CL, and Terando, AM. "Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study." Annals of surgical oncology 24, no. 9 (September 2017): 2728-2733.

PMID
28508145
Full Text

Overman, MJ, McDermott, R, Leach, JL, Lonardi, S, Lenz, H-J, Morse, MA, Desai, J, Hill, A, Axelson, M, Moss, RA, Goldberg, MV, Cao, ZA, Ledeine, J-M, Maglinte, GA, Kopetz, S, and André, T. "Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study." The Lancet. Oncology 18, no. 9 (September 2017): 1182-1191.

PMID
28734759
Full Text

Chawla, S, Van Tine, BA, Pollack, S, Ganjoo, K, Elias, A, Riedel, RF, Attia, S, Choy, E, Okuno, S, Agulnik, M, von Mehren, M, Livingston, M, Keedy, V, Verschraegen, C, Philip, T, Bohac, C, Lu, H, Chen, M, and Maki, R. "A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival." September 2017.

Scholars@Duke

Thompson, EM, Keir, ST, Venkatraman, T, Lascola, C, Yeom, KW, Nixon, AB, Liu, Y, Picard, D, Remke, M, Bigner, DD, Ramaswamy, V, and Taylor, MD. "The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival." Neuro-oncology 19, no. 9 (September 2017): 1217-1227.

PMID
28379574
Full Text

Humeniuk, MS, Zhang, T, and Armstrong, AJ. "Exploiting DNA damage without repair: The activity of platinum chemotherapy in BRCA-mutated prostate cancers." Cancer 123, no. 18 (September 2017): 3441-3444.

PMID
28608923
Full Text

Pages